TLR10 Gene

Introduction

TLR10 encodes Toll-Like Receptor 10, a member of the TLR family that is unique among human TLRs for several reasons. It is the only TLR gene located in a TLR gene cluster (with TLR1 and TLR6) on chromosome 4p14, and it represents the least characterized human TLR due to its lack of functional expression in commonly used model systems. Despite these challenges, emerging research indicates that TLR10 plays important roles in innate immunity, inflammation modulation, and potentially in neuroinflammatory conditions affecting the central nervous system^{1Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells2001 · Biochim Biophys Acta}. ^{1Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells2001 · Biochim Biophys Acta}

Overview

TLR10 is a type I transmembrane pattern recognition receptor belonging to the TLR1/2/6/10 subfamily. Unlike other TLRs, TLR10 has proven difficult to study because it does not signal efficiently in standard cell lines, and for many years it was considered a pseudogene in mice. However, human TLR10 is a functional receptor with distinct characteristics:

• Co-receptor function: Acts primarily as a co-receptor rather than a primary pattern recognition receptor

• Modulatory effects: Can inhibit signaling from TLR2-containing heterodimers

• Adaptive immunity: Involved in B cell responses and antibody production

• Brain expression: Present in microglia and other brain cells

The unique genomic organization of TLR10, TLR1, and TLR6 in a tandem array suggests they evolved through gene duplication and may have overlapping or compensatory functions.

Protein Structure and Function

Domain Architecture

TLR10 contains the characteristic TLR domain organization:

1. Leucine-Rich Repeat (LRR) domain: Extracellular region containing 20-25 LRRs

   • LRR CT (C-terminal): Ligand recognition

   • LRRs: Non-consecutive repeats of LxxLxLxxN motif

   • N-glycosylation sites for proper folding

2. Transmembrane domain: Single pass α-helical segment

   • Position: Amino acids 600-620

   • Anchors receptor in plasma membrane/endosomal membrane

3. TIR (Toll/IL-1 Receptor) domain: Cytoplasmic signaling domain

   • BB loop: Critical for adapter protein interactions

   • Conserved motifs: Box 1 and Box 2

Structural Features Unique to TLR10

• LRR 3: Contains an insertion unique among TLRs

• TIR domain: Has specific residues that affect signaling

• Glycosylation: Multiple N-linked glycosylation sites

Signaling Mechanisms

TLR10 signaling is complex and differs from other TLRs:

MyD88-Dependent Pathway (primary):

• TLR10 recruits MyD88 through TIR domain interactions

• Activates IRAK4, IRAK1/2, TRAF6

• Leads to NF-κB and MAPK activation

• Results in pro-inflammatory cytokine production

Negative Regulation:

• TLR10 can inhibit TLR2/TLR1 and TLR2/TLR6 signaling

• Acts as a decoy receptor in some contexts

• May regulate excessive inflammation

B Cell-Specific Signaling:

• Associates with B cell receptor complex

• Enhances antibody responses to certain antigens

• Requires co-localization in lipid rafts

Brain Expression and Function

Cellular Distribution

Regional Expression

TLR10 expression in the brain is lower than other TLRs (TLR2, TLR4) but is detectable in:

• Cerebral cortex

• Hippocampus (particularly CA1 and dentate gyrus)

• Cerebellum

• Substantia nigra

Functions in the CNS

1. Microglial activation: Modulates cytokine production in response to pathogens

2. Neuroprotection: May have anti-inflammatory effects through heterodimer inhibition

3. Disease modification: Genetic variants may alter brain inflammatory responses

Disease Associations

Alzheimer’s Disease

Association: TLR10 genetic variants have been linked to AD risk in some populations^{4Toll-like receptor polymorphisms and Alzheimer's disease: a systematic review and meta-analysis2018 · J Alzheimers Dis}

Mechanisms:

• Recognition of amyloid-associated microbial components

• Modulation of microglial inflammatory responses

• Potential role in amyloid clearance

• Interaction with TLR2/TLR6 heterodimers

Evidence:

• GWAS studies have identified TLR10 polymorphisms associated with AD

• Expression studies show altered TLR10 in AD brain

• In vitro models suggest role in Aβ-induced inflammation

Parkinson’s Disease

Association: TLR10 implicated in PD pathogenesis^{2Toll-like receptors in neurodegenerative diseases2019 · Exp Neurobiol}

Mechanisms:

• Recognition of α-synuclein aggregates

• Modulation of microglial responses to neuron-derived proteins

• Potential involvement in Lewy body formation

Evidence:

• TLR10 expression increased in PD substantia nigra

• Polymorphisms associated with PD risk in some studies

Autoimmune Disorders

Association: Altered TLR10 in various autoimmune conditions

Specific Associations:

• Systemic lupus erythematosus (SLE)

• Rheumatoid arthritis

• Inflammatory bowel disease

Mechanism: Dysregulated TLR10 may contribute to autoimmunity through altered immune cell activation thresholds.

Atherosclerosis

Association: TLR10 plays roles in cardiovascular disease

Mechanisms:

• Recognition of oxidized lipids

• Modulation of plaque inflammation

• Effects on endothelial cell activation

Tuberculosis

Association: TLR10 variants influence TB susceptibility

Evidence:

• Specific SNPs associated with protection or susceptibility

• Different allele frequencies in TB patient populations

Genetic Variants

Polymorphisms

Functional Variants

• rs5743810:编码 change affecting TIR domain signaling

• rs5743809: Promoter variant affecting basal expression

• Haplotype variants: Specific combinations associated with disease

Therapeutic Implications

Targeting TLR10

Therapeutic Potential

1. Anti-inflammatory therapy: TLR10 agonists could reduce excessive inflammation

2. Autoimmune modulation: TLR10 targeting in B cell-mediated autoimmunity

3. Neurodegeneration: Modulating brain inflammation

4. Infectious disease: Enhancing antimicrobial immunity

Challenges

• Limited understanding of TLR10 ligands

• Complexity of signaling networks

• Species differences in TLR10 function

• Lack of specific pharmacological tools

Research Tools and Models

Experimental Systems

• Cell lines: HEK293 (with MyD88), B cell lines

• Primary cells: Human monocytes, B cells, microglia

• Animal models: Transgenic mice expressing human TLR10

Ligand Identification

Known and potential TLR10 ligands include:

• Synthetic TLR10-specific agonists

• Lipoproteins from various pathogens

• Heat shock proteins (controversial)

• Amyloid-beta (in the context of AD)

Comparison with TLR1 and TLR6

TLR10 is most closely related to TLR1 and TLR6:

Unanswered Questions

1. What are the specific physiological ligands of TLR10?

2. How does TLR10 signaling differ between cell types?

3. Can TLR10 modulation treat inflammatory diseases?

4. What is the role of TLR10 in normal brain function?

5. How do TLR10 variants affect disease risk?

See Also

• Toll-Like Receptors

• TLR1

• TLR2

• TLR6

• Neuroinflammation

• Microglia

• Alzheimer’s Disease

• Parkinson’s Disease

• Innate Immune Signaling

External Links

• NCBI Gene: TLR10

• UniProt: TLR10

• Ensembl: TLR10

• OMIM: TLR10